European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S. investment. The $200 billion pharma company intends to invest $23 ...

The Indian stock market witnessed a sharp rally, with investors adding Rs 18.42 lakh crore to their wealth in two days. The surge was driven by global equity gains and a potential easing of US tariffs ...